Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.590
0.00 (-0.01%)
Apr 29, 2026, 11:16 AM EDT - Market open
Kairos Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 13 | 15 | 20 | - | - | - | |
| Market Cap Growth | -8.71% | -24.29% | - | - | - | - | |
| Enterprise Value | 8 | 9 | 16 | - | - | - | |
| Last Close Price | 0.59 | 0.71 | 1.52 | - | - | - | |
| PB Ratio | 1.94 | 2.33 | 4.09 | - | - | - | |
| P/TBV Ratio | 2.01 | 2.35 | 4.29 | - | - | - | |
| Debt / Equity Ratio | - | - | - | -0.31 | -0.50 | -0.34 | |
| Net Debt / Equity Ratio | -0.71 | -0.71 | -0.27 | -0.26 | -0.13 | -0.28 | |
| Net Debt / EBITDA Ratio | 0.83 | 0.83 | 0.58 | -0.35 | -0.36 | -0.17 | |
| Quick Ratio | 22.57 | 22.57 | 1.28 | 0.04 | 0.27 | 0.04 | |
| Current Ratio | 27.07 | 27.07 | 4.20 | 0.04 | 0.27 | 0.04 | |
| Return on Equity (ROE) | -97.99% | -97.99% | -192.96% | - | - | - | |
| Return on Assets (ROA) | -56.59% | -56.59% | -43.50% | -107.07% | -39.41% | -307.71% | |
| Return on Capital Employed (ROCE) | -87.90% | -87.90% | -49.10% | 119.00% | 95.60% | 166.50% | |
| Earnings Yield | -43.12% | -36.85% | -13.33% | - | - | - | |
| Buyback Yield / Dilution | -62.27% | -62.27% | -9.38% | -1.42% | -11.86% | 3.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.